Literature DB >> 26001722

Beneficial effects of exogenous CDP-choline (citicoline) in EAE.

Pawel Grieb1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26001722     DOI： 10.1093/brain/awv140

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  5 in total

Review 1.  An unmet clinical need: roads to remyelination in MS.

Authors:  Peter Göttle; Moritz Förster; Vivien Weyers; Patrick Küry; Konrad Rejdak; Hans-Peter Hartung; David Kremer
Journal:  Neurol Res Pract       Date:  2019-07-08

2.  Serum Levels of the Biomarkers Associated with Astrocytosis, Neurodegeneration, and Demyelination: Neurological Benefits of Citicoline Treatment of Patients with Ischemic Stroke and Atrial Fibrillation.

Authors:  O V Kuryata; Yu S Kushnir; V S Nedzvetsky; V V Korsa; A A Tykhomyrov
Journal:  Neurophysiology       Date:  2021-11-30       Impact factor: 0.587

Review 3.  Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma.

Authors:  Pawel Grieb; Anselm Jünemann; Marek Rekas; Robert Rejdak
Journal:  Front Aging Neurosci       Date:  2016-04-08       Impact factor: 5.750

4.  The choline pathway as a strategy to promote central nervous system (CNS) remyelination.

Authors:  Thomas Skripuletz; Ralf A Linker; Martin Stangel
Journal:  Neural Regen Res       Date:  2015-09       Impact factor: 5.135

5.  Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke.

Authors:  Huanling Liu; Anna Jablonska; Yuguo Li; Suyi Cao; Dexiang Liu; Hanwei Chen; Peter Cm Van Zijl; Jeff W M Bulte; Miroslaw Janowski; Piotr Walczak; Guanshu Liu
Journal:  Theranostics       Date:  2016-06-18       Impact factor: 11.556
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.